Publications by authors named "Uwe Haag"

Claim this Profile
H
Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.
Pedro Marques da Silva, Uwe Haag, Julian F Guest, John E Brazier, Marco Soro

Health Qual Life Outcomes· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
Robert Fledrich, Beate Schlotter-Weigel, Tuuli J Schnizer, Sven P Wichert, Ruth M Stassart, Uwe Haag

Brain· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Vivencio Barrios, Peter Brommer, Uwe Haag, Alberto Calderón, Carlos Escobar

Clin Drug Investig· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
Massimo Volpe, Cristina Miele, Uwe Haag

Clin Drug Investig· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Massimo Volpe, Peter Brommer, Uwe Haag, Cristina Miele

Clin Drug Investig· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis